CA Piccirillo, EM Shevach. (2001) "Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells." J Immunol 167. 1137-40 PMID: 11466326 | Abstract and Keywords
JP McGettigan, S Sarma, JM Orenstein, RJ Pomerantz, MJ Schnell. (2001) "Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector." J Virol 75. 8724-32 PMID: 11507217 | Abstract and Keywords
XL Zhang, S Zhao, SH Borenstein, Y Liu, B Jayabalasingham, JW Chamberlain. (2001) "CD8 expression up to the double-positive CD3(low/intermediate) stage of thymic differentiation is sufficient for development of peripheral functional cytotoxic T lymphocytes." J Exp Med 194. 685-93 PMID: 11535636 | Abstract and Keywords
RA Baiocchi, JS Ward, L Carrodeguas, CF Eisenbeis, R Peng, S Roychowdhury, S Vourganti, T Sekula, M O'Brien, M Moeschberger, MA Caligiuri. (2001) "GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder." J Clin Invest 108. 887-94 PMID: 11560958 DOI: 10.1172/JCI12932 | Abstract and Keywords
S Fujii, K Shimizu, T Shimizu, MT Lotze. (2001) "Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ." Blood 98. 2143-51 PMID: 11568001 | Abstract and Keywords
OF Bathe, N Dalyot-Herman, TR Malek. (2001) "IL-2 during in vitro priming promotes subsequent engraftment and successful adoptive tumor immunotherapy by persistent memory phenotypic CD8(+) T cells." J Immunol 167. 4511-7 PMID: 11591778 | Abstract and Keywords
MP Velders, S McElhiney, MC Cassetti, GL Eiben, T Higgins, GR Kovacs, AG Elmishad, WM Kast, LR Smith. (2001) "Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA." Cancer Res 61. 7861-7 PMID: 11691804 | Abstract and Keywords
TN Bullock, DW Mullins, TA Colella, VH Engelhard. (2001) "Manipulation of avidity to improve effectiveness of adoptively transferred CD8(+) T cells for melanoma immunotherapy in human MHC class I-transgenic mice." J Immunol 167. 5824-31 PMID: 11698456 | Abstract and Keywords